The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "allopurinol"

Search results for: allopurinol

Allopurinol for Gout an Unlikely Contributor to Kidney Disease

October 8, 2018 • By Reuters Staff

NEW YORK (Reuters Health)—Allopurinol does not appear to contribute to decline in kidney function and may actually protect renal function in patients with gout, according to a large population-based study. Gout affects around 4% of Americans and often occurs alongside chronic kidney disease (CKD), Dr. Tuhina Neogi from Boston University School of Medicine and colleagues… [Read More]

Filed Under: Conditions, Crystal Arthritis Tagged With: Allopurinol, chronic kidney disease, Gout, kidney

FDA Approves Lesinurad + Allopurinol

September 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

Duzallo, a combination of lesinurad and allopurinol, was approved by the FDA in August to treat hyperuricemia associated with gout…... [Read More]

Filed Under: Drug Updates Tagged With: Allopurinol, Duzallo, FDA, Food and Drug Administration, Gout, hyperuricemia, lesinurad, U.S. Food and Drug Administration

Allopurinol Appears More Renoprotective than Febuxostat in Older Adults

July 20, 2017 • By Reuters Staff

NEW YORK (Reuters Health)—The renal protective effect of allopurinol appears to differ from that of febuxostat in the elderly, according to new research. The study, of a nationally representative sample of Medicare patients, showed that allopurinol was associated with a greater reduction in the risk of incident kidney disease, report the authors online July 13… [Read More]

Filed Under: Conditions, Drug Updates Tagged With: Allopurinol, Febuxostat, kidney disease, Medicare patients, renal protective effect

Lesinurad with Allopurinol When Allopurinol Alone Is Insufficient

December 29, 2016 • By Arthritis & Rheumatology

Current guidelines for the long-term management of gout recommend a combination of lifestyle management and/or pharmacotherapy to lower serum UA levels to <6.0 mg/dL in most patients or <5.0 mg/dL in patients with more severe disease. Allopurinol is the most widely used xanthine oxidase inhibitor and is recommended in treatment guidelines as a first-line urate-lowering… [Read More]

Filed Under: Conditions, Crystal Arthritis Tagged With: Allopurinol, Arthritis & Rheumatology, Gout, lesinurad, Uric acid

Blacks, Asians at Higher Risk for Allopurinol-Related Skin Reactions

September 8, 2016 • By Deborah Levenson

Be careful when prescribing allo­purinol to black and Asian gout patients, a study newly advises. Black and Asian patients who take this ubiquitous, more-than-40-year-old medication are at much higher risk of certain serious skin reactions than are Caucasians or Hispanics. Compared with Caucasians, blacks who take allopurinol to lower blood urate levels have an increased… [Read More]

Filed Under: Conditions, Drug Updates Tagged With: Allopurinol, Asian, black, Gout, outcome, patient care, rheumatologist, risk, skin reaction, Treatment, Uric acid

Dr. Ethan Craig Picks His Favorite Gout Abstracts from ACR Convergence 2020

November 19, 2020 • By Keri Losavio

In light of the release of the ACR’s new gout guideline, it’s not surprising that 50 abstracts of studies on various aspects of gout were accepted at ACR Convergence 2020. Here, we highlight just a few:... [Read More]

Filed Under: ACR Convergence, Crystal Arthritis, Meeting Reports Tagged With: ACR Convergence 2020, ACR Convergence 2020 – Gout, Gout, pegloticase, serum uric acid

Optimize Gout Management with the Latest Evidence-Based Guidance

November 17, 2020 • By Mary Beth Nierengarten

ACR Convergence 2020—In May 2020, the ACR published its updated guideline for the management of gout.1 It followed on the heels of a 2017 gout guideline published by the American College of Physicians.2 Although the guidelines provide similar recommendations on the treatment of acute gout, they differ importantly in the use of uric acid-lowering therapy… [Read More]

Filed Under: ACR Convergence, Conditions, Crystal Arthritis, Guidelines, Meeting Reports Tagged With: ACR Convergence 2020, ACR Convergence 2020 – Gout, Gout

FAST Results for Febuxostat Safety in Gout Patients

November 12, 2020 • By Keri Losavio

ACR CONVERGENCE 2020—The results of a post-authorization study comparing the cardiovascular safety of febuxostat vs. allopurinol were presented in a late-breaking abstract session at the ACR’s fully virtual annual meeting on Monday, Nov. 9. Cardiologist Thomas MacDonald, MD, FRCP, MBChB, clinical professor (teaching and research) of molecular and clinical medicine, University of Dundee School of… [Read More]

Filed Under: ACR Convergence, Conditions, Crystal Arthritis, Meeting Reports Tagged With: ACR Convergence 2020, ACR Convergence 2020 – Gout, CARES study

Advantages of Embedding a Specialty Pharmacist in a Rheumatology Clinic

November 12, 2020 • By Polly J. Ferguson, MD, Jessica Lynton, PharmD, BCPS, & Beth H. Resman-Targoff, PharmD, FCCP, on behalf of the ARP Membership & Nominations Committee

The number of medications with rheumatologic indications has increased in parallel with expanding complexities of medication approval and delivery. Simply starting a patient on a biologic medication or new disease-modifying anti-rheumatic drug (DMARD) can be time consuming and frustrating for physicians, nurses and their support staff. In addition to educating the patient and obtaining prior… [Read More]

Filed Under: Drug Updates, From the College, Practice Management Tagged With: adherence, ARP, pharmacist, prior authorization

The 2020 ACR Awards of Distinction & Masters Class

November 12, 2020 • By Linda Childers

Presidential Gold Medal The highest award the ACR can bestow, the Presidential Gold Medal is awarded in recognition of outstanding achievements in rheumatology over an entire career. This year’s award went to James O’Dell, MD, the Stokes-Shackleford Professor of Internal Medicine, vice chair of internal medicine and chief of the Division of Rheumatology at the… [Read More]

Filed Under: Awards Tagged With: ACR Convergence 2020, Ciarán M. Duffy, Dr. Abby Abelson, Dr. Ami Aalok Shah, Dr. Andras Perl, Dr. Angela Tincani, Dr. Bernardo A. Pons-Estel, Dr. Brian F. Mandell, Dr. Carlos J. Lozada, Dr. Daniel Solomon, Dr. Edward K.L. Chan, Dr. Emily Isaacs, Dr. James O’Dell, Dr. James R. Seibold, Dr. James Witter, Dr. Joanne M. Jordan, Dr. Kara Petersen, Dr. Kathleen M. O’Neil, Dr. Leonard H. Sigal, Dr. M. Virginia Pascual, Dr. Martin Jan Bergman, Dr. Michael B. Brenner, Dr. Nancy E. Lane, Dr. Norman T. Ilowite, Dr. Pamela Weiss, Dr. Pierre Miossec, Dr. Robert Warren, Dr. Sheldon Solomon, Dr. Stuart Kassan

  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.